KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues

KRAS mutation has been unambiguously identified as a marker of resistance to cetuximab-based treatment in metastatic colorectal cancer (mCRC) patients. However, most studies of KRAS mutation analysis have been performed using homogenously archived CRC specimens, and studies that compare freshly froz...

Descripción completa

Detalles Bibliográficos
Autores principales: Solassol, Jérome, Ramos, Jeanne, Crapez, Evelyne, Saifi, Majda, Mangé, Alain, Vianès, Evelyne, Lamy, Pierre-Jean, Costes, Valérie, Maudelonde, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116185/
https://www.ncbi.nlm.nih.gov/pubmed/21686179
http://dx.doi.org/10.3390/ijms12053191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116185/
https://www.ncbi.nlm.nih.gov/pubmed/21686179
http://dx.doi.org/10.3390/ijms12053191

Ejemplares similares